Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis
暂无分享,去创建一个
Robert L. Davis | M. Carrington | L. Trepanier | T. Manolio | M. Pirmohamed | M. Lee | J. Denny | H. McLeod | C. Hutter | M. Mockenhaupt | W. Chantratita | D. Veenstra | R. Yuliwulandari | E. Phillips | N. Shear | M. Avigan | W. Chung | S. Hung | C. Sung | S. Mahasirimongkol | R. Cibotti | M. Pacanowski | L. Wheatley | J. Lertora | W. Suwankesawong | S. Tumminia | L. Grenade | J. Leeder | Simone P. Pinheiro | Andrea D. Dalton
[1] W. Chung,et al. Pharmacogenomic Advances in the Prediction and Prevention of Cutaneous Idiosyncratic Drug Reactions , 2017, Clinical pharmacology and therapeutics.
[2] E. Phillips,et al. Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. , 2017, The journal of allergy and clinical immunology. In practice.
[3] M. Mockenhaupt,et al. Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options. , 2017, Current pharmaceutical design.
[4] J. Silverberg,et al. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults. , 2016, Journal of Investigative Dermatology.
[5] Melissa A. Basford,et al. Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network , 2016, Clinical pharmacology and therapeutics.
[6] S. Mallal,et al. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. , 2015, The Journal of allergy and clinical immunology.
[7] Thachanan Kongpan,et al. Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions , 2015, Pharmacogenetics and genomics.
[8] M. Nelson,et al. The International Serious Adverse Events Consortium , 2014, Nature Reviews Drug Discovery.
[9] M. Schumacher,et al. A marker for Stevens-Johnson syndrome …: ethnicity matters , 2006, The Pharmacogenomics Journal.
[10] Yuan-Tsong Chen,et al. A marker for Stevens–Johnson syndrome , 2004 .
[11] M. Mockenhaupt,et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. , 1996, Journal of clinical epidemiology.